Novogen Ltd (NASDAQ:NVGN)

Wednesday’s Trading Day
3.36 +0.85 / +33.62%
As of Mar 04
Day’s Change
Thursday’s Pre-Market   Switch to standard view »
3.05 -0.31 / -9.23%
 
Volume: 3.0K

Today’s Trading

Previous close2.51
Today’s open3.72
Day’s range3.25 - 4.33
Volume19,121,412
Average volume (3 months)1,053,228
Market cap$17.0M
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)+18.04%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book13.87

Competitors

 Today’s
change
Today’s
% change
CDXICardax Inc+0.05+19.23%
CPHIChina Pharma Holding...-0.03-6.90%
DARADARA BioSciences Inc-0.09-9.57%
RTGNRuthigen Inc-0.08-2.07%
Data as of 9:40am ET, 03/04/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Graham Edmund Kelly
Chief Financial Officer &
Non-Executive Director
Steven Coffey
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account